CRISPR Therapeutics' lone approved product isn't generating much revenue yet. The company has made little clinical progress elsewhere in recent years. Though there are risks, if CRISPR Therapeutics' ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results